CSF3 and bacterial infectious disease: However, in the study by Engelmann (10), all G-CSF-treated ACLF patients had a poor pre-existing liver base (liver cirrhosis), more than 65.9% suffered from extrahepatic organ failure, and up to 56.8% had bacterial infection at baseline.